Bristol-Myers Squibb

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Thu, 10/2/14 - 09:34 am
Celgene
Novartis
Eli Lilly
JNJ
Bristol-Myers Squibb
Biogen Idec
ESMO: The latest skinny on drugs from Pfizer, Novartis, GSK, Merck, BMS
Fierce Pharma
Tue, 09/30/14 - 10:08 am
ESMO
Pfizer
Novartis
GSK
Merck
Bristol-Myers Squibb
AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market
Bidness Etc.
Mon, 09/29/14 - 10:31 am
Merck
Bristol-Myers Squibb
AstraZeneca
MEDI4736
cancer immunotherapy
Bristol immune drug shows strong effect in melanoma study
Yahoo/Reuters
Mon, 09/29/14 - 07:46 am
Bristol-Myers Squibb
Opdivo
melanoma
Bristol-Myers blueprints a 2,500-worker campus in New Jersey
Fierce Biotech
Thu, 09/25/14 - 09:27 am
Bristol-Myers Squibb
New Jersey
BMS striving to push Opdivo past Keytruda
Medical Marketing and Media
Wed, 09/17/14 - 09:52 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
anti-PD-1 immunotherapy
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Mon, 09/15/14 - 10:10 am
Bristol-Myers Squibb
Merck
GSK
Novo Nordisk
Sanofi
Novartis
Pfizer
Biogen Idec
Roche
Bristol-Myers Needs a Healthy Growth Shot to Justify Its Valuation
TheStreet.com
Tue, 09/9/14 - 08:05 am
Bristol-Myers Squibb
Roche's RoACTEMRA To Go Up Against Anti-Rheumatoid Arthritis Drugs From Bristol-Myers, AbbVie
Bidness Etc.
Mon, 09/8/14 - 12:29 pm
Roche
rheumatoid arthritis
RoActemra
AbbVie
Bristol-Myers Squibb
Bristol-Myers Sues Merck Over Cancer Immunotherapy Patent
Bloomberg
Fri, 09/5/14 - 04:02 pm
Bristol-Myers Squibb
Merck
Keytruda
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Fri, 09/5/14 - 10:04 am
Merck
melanoma
Keytruda
Bristol-Myers Squibb
Opdivo
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Motley Fool
Thu, 09/4/14 - 09:56 am
JNJ
Eliquis
Bristol-Myers Squibb
Xarelto
bloodthinners
Bristol-Myers dumps $1B-plus Alder deal, punts rheumatoid arthritis drug
Fierce Biotech
Tue, 09/2/14 - 11:21 am
Bristol-Myers Squibb
Alder Biopharma
rheumatoid arthritis
clazakizumab
J&J And Bristol-Myers Changing The Myeloma Drug Landscape
Bidness
Sun, 08/31/14 - 10:03 am
JNJ
Bristol-Myers Squibb
myeloma
Multiple Myeloma
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer
Yahoo/The Street
Wed, 08/27/14 - 09:52 am
Akamai
Bristol-Myers Squibb
Merck
Eli Lilly
Pfizer
3 Reasons Bristol-Myers Squibb's Stock Could Rise
Motley Fool
Sat, 08/23/14 - 10:17 am
Bristol-Myers Squibb
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod
Yahoo/Zacks
Sat, 08/23/14 - 09:45 am
Bristol-Myers Squibb
Eliquis
deep vein thrombosis
pulmonary embolism
FDA approves Pfizer, Bristol-Myers' blood thinner for new indication against blood clots
Yahoo/AP
Thu, 08/21/14 - 04:03 pm
FDA
bloodthinners
Pfizer
Bristol-Myers Squibb
Eliquis
Most Popular News Headlines For Wednesday, August 13 2014
CP Wire
Thu, 08/14/14 - 10:11 am
Pfizer
Bristol-Myers Squibb
Eliquis
Belsomra
insomnia
Kyprolis
Aranesp
Amgen
InterMune
Sanofi
Roche

Pages